Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03037762
Other study ID # 01072014
Secondary ID
Status Completed
Phase
First received
Last updated
Start date October 2014
Est. completion date October 2017

Study information

Verified date November 2019
Source University Hospital Muenster
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Neurogenic dysphagia is one of the most frequent and prognostically relevant neurological deficits in a variety of disorders, such as stroke, parkinsonism and advanced neuromuscular diseases. Flexible endoscopic evaluation of swallowing (FEES) is now probably the most frequently used tool for objective dysphagia assessment in Germany. It allows evaluation of the efficacy and safety of swallowing, determination of appropriate feeding strategies and assessment of the efficacy of different swallowing manoeuvres. The literature furthermore indicates that FEES is a safe and well-tolerated procedure. The FEES-Registry aims at evaluating findings and side effects of FEES in a heterogeneous collective of patients with neurogenic dysphagia.


Recruitment information / eligibility

Status Completed
Enrollment 2401
Est. completion date October 2017
Est. primary completion date August 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion criteria:

- suspected neurogenic dysphagia

- Patients being scheduled for a FEES

- written informed consent

Exclusion criteria:

- none

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Flexible Endoscopic Evaluation of Swallowing


Locations

Country Name City State
Germany University Hospital Muenster

Sponsors (1)

Lead Sponsor Collaborator
University Hospital Muenster

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary FEES-related side effects - 1. systolic blood pressure increase Systolic blood pressure will be measured directly prior, during and after the procedure. The initial value will be compared to the highest blood pressure value measured during/directly after the procedure. during the procedure
Primary FEES-related side effects - 2. Oxygen saturation decline Oxygen saturation will be measured directly prior, during and directly after the procedure. The initial value will be compared to the lowest value measured during/directly after the procedure. during the procedure
Primary FEES-related side effects - 3. Heart rate decrease Heart rate will be measured directly prior, during and directly after the procedure. The initial value will be compared to the lowest value measured during/directly after the procedure. during the procedure
Primary FEES-related side effects - 4. Nose bleed Number of patients with nose bleed during the procedure during the procedure
Primary FEES-related side effects - 5. Laryngospasm Number of patients with laryngospasm during the procedure during the procedure
Primary FEES-related side effects - 6. Decreased level of consciousness Number of patients with a decline in consciousness during the procedure (measured with the Richmond agitation and sedation scale) during the procedure
Primary Patients subjective FEES-related discomfort Number of patients with procedure related discomfort measured with a 4 point scale ranging from 1=no discomfort to 4=extremely painful sensation during the procedure during the procedure
Secondary Changes of dietary status after FEES Dietary status will be assessed directly prior to the procedure and immediately thereafter. Dietary status will be assessed with the Functional Oral Intake Scale (FOIS scale). immediately prior and immediately after the procedure
See also
  Status Clinical Trial Phase
Terminated NCT02493491 - Neurogenic Dysphonia/Dysphagia Registry N/A
Completed NCT01995929 - Functional Endoscopy in Neurogenic Dysphagia
Recruiting NCT05190718 - Register Study: Implementation of Pharyngeal Electrostimulation Therapy for the Treatment of Acute Neurogenic Dysphagia
Completed NCT03241615 - Dysphagia Symptom Severity and Quality of Life
Completed NCT05782790 - Action Observation Therapy Program in Patients With Neurogenic Dysphagia N/A